Received: 1 October 2019
Accepted: 6 February 2020
First Online: 14 February 2020
Ethics approval and consent to participate
: Approved by the University of British Columbia-Providence Health Care Research Ethics Board (UBC-PHC REB), of the UBC-PHC Research Institute. Individual participant consent was deemed unnecessary by Canadian regulations as laid out in Article 3.7 of the TCPS2 as this study meets requirements defined for minimal risk research.
: Not applicable.
: • CT, KK: declares that they have no competing interests.• MS:• Fellowship grant received from Pfizer in 2015 ($10000)• Unrestricted research grant received from Pfizer in 2018 ($10000) for urinary incontinence research• Paid speaking engagements for Pfizer and Astellas on urinary incontinence (2017, 2019)